CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness [Phase 1]

Feasibility Phase 1 trial of a tailored smoking cessation app for individuals with serious mental illness has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Duke University | Conditions: Nicotine Addiction, Serious Mental Illness | Phase 1 | Status: COMPLETED | Results posted: 2020-03-23